Cart
sales@molnova.com
SARS-CoV-2-IN-38
CAS No. 2882823-27-8
SARS-CoV-2-IN-38( —— )
Catalog No. M37222 CAS No. 2882823-27-8
SARS-CoV-2-IN-38 is an orally available SARS-CoV-2 inhibitor with potential antiviral activity for the study of SARS viral infections.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 411 | In Stock |
|
| 10MG | 562 | In Stock |
|
| 25MG | 866 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameSARS-CoV-2-IN-38
-
NoteResearch use only, not for human use.
-
Brief DescriptionSARS-CoV-2-IN-38 is an orally available SARS-CoV-2 inhibitor with potential antiviral activity for the study of SARS viral infections.
-
DescriptionSARS-CoV-2-IN-38 (compound 24) is a SARS-CoV-2 inhibitor with good oral bioavailability in mice (F%=39.75%).
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorSARS-CoV
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2882823-27-8
-
Formula Weight419.76
-
Molecular FormulaC18H14ClF4NO4
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C(OC1=CC(F)=C(Cl)C=C1C(=O)NC2=CC=C(OC(F)(F)F)C=C2)C(C)C
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Li R, et al. Synthesis, cytotoxicity, and pharmacokinetic evaluations of niclosamide analogs for anti-SARS-CoV-2. Eur J Med Chem. 2023 May 5;253:115320. ?
molnova catalog
related products
-
Benfotiamine
Benfotiamine, the lipid-soluble thiamine derivative used as a treatment for diabetic neuropathy.
-
Mast cell degranulat...
Mast cell degranulating peptide (28-49) is a bee venom depolarizer that can improve the cGMP content of cerebellum tablets in mice.
-
Guanosine 5'-monopho...
Guanosine monophosphate also known as guanylic acid or 5'-GMP belongs to the class of organic compounds known as purine ribonucleoside monophosphates. In particular L-Glutamic acid and guanosine monophosphate can be biosynthesized from xanthylic acid and L-glutamine; which is catalyzed by the enzyme GMP synthase.
